Grant: Master's Award: Canada Graduate Scholarships
University of Manitoba
$17,500.00
Medical Microbiology Masters Student
EF 2016-17
Résumé
Understanding LAG-3-associated defects in iNKT cell function in HIV infection. Background: Human immunodeficiency virus (HIV) is currently a worldwide issue, with 36.7 million current HIV-infected individuals and 2.1 million new infections in 2015. The hallmark of chronic HIV infection is immune exhaustion, characterized by a definitive loss of immune system effectiveness. Immune exhaustion is seen regardless of the use of anti-retroviral therapies (ART), which are the one of the most effective HIV therapeutics to date. Lymphocyte-activation gene (LAG-3), an inhibitory exhaustion marker expressed on immune cells, is associated with immune dysfunction observed in HIV patients. Our lab has shown that increased LAG-3 expression on invariant Natural Killer T (iNKT) cells correlates with decrease cell functionality in HIV infection. iNKT cells are critical contributors to a healthy immune response to viral infection, therefore dysfunctional iNKT cells render HIV-infected individuals susceptible to an abundance of pathogens. Hypothesis: In HIV infection, we hypothesize that blocking LAG-3 via an antibody blockade will restore function of iNKT cells.Approach: Our lab has experience designing blockade systems, including a LAG-3 blockade. We will execute short-term and long-term iNKT cell stimulations of HIV-infected samples with or without the presence of our LAG-3 blockade system. Through our established flow cytometry protocols, we will assess the iNKT cell population and expression of both LAG-3 and cytokines, important signalling molecules that represent the functional ability of the iNKT cells. The long-term goal is to restore immune cell function thereby controlling HIV replication and decreasing the dependency on ART.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
367032
Name
Balasko Allison
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Medical Microbiology Masters Student
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibody Therapeutic; Cytokines; Exhaustion Marker Lag-3; Hiv; Immune Exhaustion; Immunology; Inkt Cells; Innate Immune System; Microbiology; Virology
Abstract
Understanding LAG-3-associated defects in iNKT cell function in HIV infection. Background: Human immunodeficiency virus (HIV) is currently a worldwide issue, with 36.7 million current HIV-infected individuals and 2.1 million new infections in 2015. The hallmark of chronic HIV infection is immune exhaustion, characterized by a definitive loss of immune system effectiveness. Immune exhaustion is seen regardless of the use of anti-retroviral therapies (ART), which are the one of the most effective HIV therapeutics to date. Lymphocyte-activation gene (LAG-3), an inhibitory exhaustion marker expressed on immune cells, is associated with immune dysfunction observed in HIV patients. Our lab has shown that increased LAG-3 expression on invariant Natural Killer T (iNKT) cells correlates with decrease cell functionality in HIV infection. iNKT cells are critical contributors to a healthy immune response to viral infection, therefore dysfunctional iNKT cells render HIV-infected individuals susceptible to an abundance of pathogens. Hypothesis: In HIV infection, we hypothesize that blocking LAG-3 via an antibody blockade will restore function of iNKT cells.Approach: Our lab has experience designing blockade systems, including a LAG-3 blockade. We will execute short-term and long-term iNKT cell stimulations of HIV-infected samples with or without the presence of our LAG-3 blockade system. Through our established flow cytometry protocols, we will assess the iNKT cell population and expression of both LAG-3 and cytokines, important signalling molecules that represent the functional ability of the iNKT cells. The long-term goal is to restore immune cell function thereby controlling HIV replication and decreasing the dependency on ART.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Balasko, Allison
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~